UK life sciences minister

17-Jul-2014 - Last updated on 18-Jul-2014 at 09:57 GMT

Conservative MP George Freeman has been named as Minister for life sciences by the UK government and has indicated that backing the country’s biopharmaceutical and biotech sector is a big part of his plan.

Freeman joined biopharma investment fund Merlin Biosciences in 1997, led Amedis Pharma until its acquisition by Takeda in 2004 and subsequently worked at academic, pharma and hospital project matchmaker 4D before becoming an MP in 2010.

Genfit for purpose: analyst predicts gains on NASH market

Pharming gets US FDA approval after all

UK investor backs biopharmas, big and small

UK names ex biopharma VC investor as life sciences minister

Also this week:

Related news

Related products

ICH M10 Guidance: Harmonization and Modification to Bioanalytical Method Variation

Content provided by WuXi AppTec | 20-Oct-2023 | Application Note

Global regulatory standards govern bioanalytical method development, validation and the subsequent assays. When those standards are updated, industry stakeholders...

Internal Standard (IS) Variation Case Studies: Emerging from Three Common IS Challenges

Content provided by WuXi AppTec | 20-Oct-2023 | Application Note

The use of internal standards (IS) is essential for developing and applying liquid chromatography-tandem mass spectrometric (LC-MS/MS) quantitative bioanalytical...

Difco TC Yeastolate UF in scale-up optimization

Content provided by Thermo Fisher Scientific Gibco Culture for Bioprocessing | 16-Oct-2023 | White Paper

Review the impact of—not only adding peptones as a supplement to your cell culture—but also the importance of concentration and timing as a feed strategy...